Literature DB >> 16829616

Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia.

Belete Tegbaru1, Dawit Wolday, Tsehaynesh Messele, Mengistu Legesse, Yared Mekonnen, Frank Miedema, Debbie van Baarle.   

Abstract

To investigate whether low CD4+ T-cell counts in healthy and human immunodeficiency virus (HIV)-infected Ethiopians influence tuberculosis (TB) immunological memory, tuberculin skin test (TST) conversion and reactivity rates were investigated among adults with and without HIV infection in urban settings in Ethiopia. Reaction to the TST was analyzed with purified protein derivative by the Mantoux technique. A total of 1,286 individuals with TST results of > or = 5-mm (n = 851) and < or = 4-mm (n = 435) induration diameters were included. Individuals with < or = 4-mm induration sizes were followed up for 21.4 +/- 9.5 months (mean +/- standard deviation) to observe skin test conversion. The overall TST reactivity (> or = 5-mm induration diameter) was 66.2% (n = 851). Reactivity was significantly lower among HIV-positive persons (40.5%) than among HIV-negative persons (68.7%) (P < 0.001). Of the above persons, 32 incident TB patients were checked for their TST status 13.05 +/- 11.1 months before diagnosis and reactivity was found among 22 (68.7%) of them. Of the TST-negative persons with 0- to 4-mm indurations who were followed up for 3 years, the conversion rate to positivity was 17.9/100 person-years of observation (PYO) (14.4/100 PYO and 18.3/100 PYO in HIV-positive and -negative persons, respectively). Despite lower absolute CD4+ T-cell numbers in Ethiopians, higher TST conversion and reactivity rates show the presence of a higher rate of latent TB infection and/or transmission. The lower TST positivity rate before a diagnosis of TB disease showed the lower sensitivity of the test. This indicates the need for other sensitive and specific diagnostic and screening methods to detect TB infection, particularly among HIV-positive persons, so that they can be given prophylactic isoniazid therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16829616      PMCID: PMC1489564          DOI: 10.1128/CVI.00098-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  29 in total

1.  Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.

Authors:  L A van Pinxteren; P Ravn; E M Agger; J Pollock; P Andersen
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Reduction in tuberculin skin-test conversions among medical house staff associated with improved tuberculosis infection control practices.

Authors:  D R Bangsberg; K Crowley; A Moss; J F Dobkin; C McGregor; H C Neu
Journal:  Infect Control Hosp Epidemiol       Date:  1997-08       Impact factor: 3.254

3.  Tuberculin skin test conversion rates in New York City Emergency Medical Service health care workers.

Authors:  D J Prezant; K J Kelly; F P Mineo; D Janus; M L Karwa; N Futterman; C Nolte
Journal:  Ann Emerg Med       Date:  1998-08       Impact factor: 5.721

4.  [Tuberculosis in health personnel: importance of surveillance and control programs].

Authors:  L Ostrosky-Zeichner; M S Rangel-Frausto; E García-Romero; A Vázquez; M J Ibarra; S Ponce de León-Rosales
Journal:  Salud Publica Mex       Date:  2000 Jan-Feb

5.  Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy.

Authors:  Tamara L Fisk; Hui-Ming Hon; Jeffrey L Lennox; C Fordham von Reyn; C Robert Horsburgh
Journal:  AIDS       Date:  2003-05-02       Impact factor: 4.177

6.  Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive ethiopians.

Authors:  D Wolday; B Hailu; M Girma; E Hailu; E Sanders; A L Fontanet
Journal:  Int J Tuberc Lung Dis       Date:  2003-02       Impact factor: 2.373

7.  Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.

Authors:  N Markowitz; N I Hansen; T C Wilcosky; P C Hopewell; J Glassroth; P A Kvale; B T Mangura; D Osmond; J M Wallace; M J Rosen; L B Reichman
Journal:  Ann Intern Med       Date:  1993-08-01       Impact factor: 25.391

8.  Risk for developing tuberculosis among anergic patients infected with HIV.

Authors:  S Moreno; J Baraia-Etxaburu; E Bouza; F Parras; M Pérez-Tascón; P Miralles; T Vicente; J C Alberdi; J Cosín; D López-Gay
Journal:  Ann Intern Med       Date:  1993-08-01       Impact factor: 25.391

Review 9.  Diagnosis of tuberculosis in children: increased need for better methods.

Authors:  E A Khan; J R Starke
Journal:  Emerg Infect Dis       Date:  1995 Oct-Dec       Impact factor: 6.883

10.  Low absolute CD4 counts in Ethiopians.

Authors:  Dawit Wolday; Aster Tsegaye; Tsehaynesh Messele
Journal:  Ethiop Med J       Date:  2002-04
View more
  8 in total

1.  Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test.

Authors:  Mengistu Legesse; Gobena Ameni; Gezahegne Mamo; Girmay Medhin; Gunnar Bjune; Fekadu Abebe
Journal:  BMC Infect Dis       Date:  2011-04-09       Impact factor: 3.090

2.  Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time.

Authors:  Liya Wassie; Abebech Demissie; Abraham Aseffa; Markos Abebe; Lawrence Yamuah; Hiwot Tilahun; Beyene Petros; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  PLoS One       Date:  2008-01-30       Impact factor: 3.240

Review 3.  The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic review.

Authors:  Andrew D Kerkhoff; Ankur Gupta; Taraz Samandari; Stephen D Lawn
Journal:  BMC Infect Dis       Date:  2013-07-08       Impact factor: 3.090

4.  Smear grading and the Mantoux skin test can be used to predict sputum smear conversion in patients suffering from tuberculosis.

Authors:  Mahmood Saffari; Hadis Alizadeh Jolandimi; Mojtaba Sehat; Nastarn Vali Nejad; Mehrdad Hedayati; Mahbobeh Zamani; Amir Ghasemi
Journal:  GMS Hyg Infect Control       Date:  2017-08-15

5.  Tuberculin Skin Test Conversion among Individuals with Human Immunodeficiency Virus Infection on Antiretroviral Therapy in a Referral Teaching Hospital, Tehran, Iran.

Authors:  Mahshid Talebi-Taher; Ladan Abbasian; Seiedeh Nina Alavi-Niakou; Seied Ali Javad-Moosavi; Seyedmahdi Pahlavani
Journal:  Tanaffos       Date:  2017

Review 6.  Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.

Authors:  Dawit Wolday; Francis M Ndungu; Gloria P Gómez-Pérez; Tobias F Rinke de Wit
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

7.  Parasitic infection may be associated with discordant responses to QuantiFERON and tuberculin skin test in apparently healthy children and adolescents in a tuberculosis endemic setting, Ethiopia.

Authors:  Liya Wassie; Abraham Aseffa; Markos Abebe; Michael Z Gebeyehu; Martha Zewdie; Adane Mihret; Girum Erenso; Menberwork Chanyalew; Hiwot Tilahun; Lawrence K Yamuah; Peter Andersen; Mark T Doherty
Journal:  BMC Infect Dis       Date:  2013-06-05       Impact factor: 3.090

8.  Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.

Authors:  Kesetebirhan Delele Yirdaw; Degu Jerene; Zewdu Gashu; M E Edginton; Ajay M V Kumar; Yohannes Letamo; Beniam Feleke; Alula M Teklu; Solomon Zewdu; Bill Weiss; Andrea Ruff
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.